I
nsulin resistance-an impairment in the ability of insulin to appropriately regulate glucose and lipid metabolism-is an early and key defect associated with weight gain (obesity), type 2 diabetes (T2D), and other disorders of metabolism. The etiology of insulin resistance is still not completely understood, but it is now clear that a strong association exists between insulin resistance and excess lipid accumulation in nonadipose tissues, particularly muscle and liver. Whether muscle cytosolic lipid accumulation causes insulin resistance still requires definitive proof, but highly plausible mechanisms have been elucidated supporting this possibility. These mechanisms involve links between metabolically active cytosolic lipid intermediates, such as diacylglycerols and ceramides, and specific steps in insulin signaling (1) (see blue shaded box in Fig. 1 ). Certainly we know that excess dietary fat intake in animals over the course of several weeks (or acute pharmacological elevation of circulating fatty acids over several hours) can cause muscle insulin resistance and that both conditions are accompanied by cytosolic lipid accumulation. Tissue accumulation of lipids could occur as a result of increased fatty acid uptake, a decreased rate of fatty acid utilization, or a combination of both. Accordingly, there has been considerable interest in recent reports that have used a variety of techniques (e.g., gene expression, 31 P-magnetic resonance spectroscopy, histological analyses) to indicate that insulin-resistant, obese, or T2D subjects have a reduced mitochondrial content and/or impaired mitochondrial function (2, 3). The conclusion from many of these studies is that mitochondrial dysfunction could be a major factor contributing to muscle lipid accumulation and insulin resistance. However, an important study by Hancock et al. (4) in this issue of PNAS shows that insulin resistance can develop in animals in response to the feeding of high-fat diets, despite a significant increase in mitochondrial content.
The Hancock et al. study (4) is significant at a number of levels. First, it clearly shows that a high-fat diet can lead to increased muscle mitochondrial content at the level of mitochondrial protein expression and mitochondrial DNA copy number. These data are compelling, particularly when combined with the other findings from this study, which show (i) an increase in the in vitro capacity of muscle from these animals to oxidize palmitate and (ii) an increase in the content of the transcription factor peroxisome proliferator-activated receptor (PPAR)␦ and the PPAR␥ coactivator 1␣ (PGC1␣), key elements in regulating mitochondrial biogenesis. As pointed out above, the question of whether high fat feeding can lead to mitochondrial dysfunction or defective fat oxidation has been controversial, with the literature fairly evenly divided on this issue. Hancock et al. provide strong and complementary data to support recent findings (5) demonstrating that skeletal muscle from mice fed a highfat diet for 5 or 20 weeks has increased mitochondrial fatty acid oxidative capacity, higher activity of oxidative enzymes, and elevated protein expression of PGC1␣ and mitochondrial respiratory chain subunits. It makes sense that animals, and presumably humans, can adapt to variations in dietary nutrient balance and increase their ability to metabolize and gain energy from the most prevalent fuel in the diet. Hancock et al.'s findings are, therefore, in accord with studies demonstrating that upstream steps in muscle lipid metabolism, such as expression of fatty acid transport proteins and activity of acylCoA synthase, are also enhanced by fat feeding (6, 7).
Hancock et al. (4) also provide evidence of a mechanism for a fatty acidinduced increase in mitochondrial biogenesis involving the muscle transcription factor PPAR␦. Their findings draw on the pivotal work of the Evans group (8), which found that fatty acids are endogenous ligands for PPAR␦ and that increased expression or activation of PPAR␦ can induce mitochondrial biogenesis. Hancock et al. observed an increase in PPAR␦ expression and activation in their high-fat-fed rats but reasoned that this increase would be insufficient to fully mediate the mitochondrial biogenic program, which would require coordinated activity of a number of transcription factors and both the nuclear and mitochondrial genomes. A key observation in interpreting their findings was the gradual increase in PGC1␣ content in the absence of any change in PGC1␣ mRNA. PGC1␣ is crucial for regulating mitochondrial biogenesis (9) , and the study results suggested a possible posttranslational regulatory link between PPAR␦ activation and PGC1␣ content. Such a link was confirmed by additional studies using in vivo muscle DNA electroporation to specifically overexpress PPAR␦, resulting in a similar increase in PGC1␣ protein but not mRNA content. The exact nature of the regulation of PGC1␣ protein by PPAR␦ activation will need further investigation, but it is in accord with other studies that show that the stability and activity of PGC1␣ can be affected by posttranslational modifications such as phosphorylation and acetylation (10, 11) . The data are also a clear example of how a distorted view could, perhaps all too often, be obtained by studies of mRNA levels without corresponding estimates of protein content, protein activity, or some other downstream or functional output of the process under investigation. The third significant aspect of the Hancock et al. study (4) is that muscle insulin resistance can develop despite increased mitochondrial content and an enhanced capacity for fat oxidation in high-fat-fed rats. This finding is interesting, although there are some caveats. Insulin resistance was not investigated in depth but was based on ex vivo glucose transport measurements in muscle strips. However, from other extensive studies in the literature that have used this and similar models, it is highly likely that in vivo muscle insulin resistance was present in these animals and was associated with increased levels of lipid intermediates. Another problem is that we do not have a complete picture of relevant in vivo lipid metabolism in these rats. Even though muscle may have an increased capacity for fat metabolism, as demonstrated here by using ex vivo methodologies, it is not possible to predict the in vivo rates from the data presented. Muscle fatty acid metabolism is subject to extensive in vivo regulation, for example, by control of fatty acid entry into the cell, transfer of fatty acid into the mitochondria (regulated by malonyl CoA at CPT-1), the capacity of ␤-oxidation and the tricarboxylic acid cycle, the electron transport chain capacity, and the degree of mitochondrial coupling (see red boxes in Fig. 1 ). Although there are many potential points of control, ultimately the rates of endogenous fatty acid oxidation are likely to be dictated by the need of the muscle for energy, rather than by its total capacity for oxidation. Respirometry data and levels of lipid intermediates in muscle would have been informative in this study to indicate the degree of enhancement of fat oxidation and tissue lipid accumulation under in vivo conditions in these animals. However, even under conditions of enhanced mitochondrial fatty acid utilization, it is still quite possible that this rate would be insufficient, in the face of increased tissue fatty acid uptake, to prevent the cytosolic lipid accumulation that leads to the development of insulin resistance. Alternatively, it is also possible that enhanced fatty acid oxidation in mitochondria may have a more direct role in reducing insulin action, given that fatty acids have been shown to promote the production of reactive oxygen species (12) , which are linked with insulin resistance (13) . Furthermore, elevated fatty acid oxidation during high fat feeding has been proposed to result in a buildup of potentially toxic incomplete lipid oxidation products that may contribute to reduced insulin sensitivity (14) . Thus, further quantitative functional studies of in vivo lipid metabolism in rats under similar study conditions will be needed before implications for insulin sensitivity can be completely understood.
Although Hancock et al. (4) demonstrate insulin resistance in the presence of improved mitochondrial function, they provide no evidence for, or against, previous findings that mitochondrial content or function is reduced in insulin-resistant humans. However, if the study results are taken at face value, it would appear unlikely that reduced muscle mitochondrial content in insulin-resistant states such as obesity or T2D is a direct result of an excessive dietary intake of fat. Indeed, when related to findings in insulin-resistant relatives of type 2 diabetics (15), the present study supports an argument that impaired mitochondrial function may be a primary (diabetogenic) defect or, as suggested (4), may be mainly due to a sedentary lifestyle, based on evidence that physical activity has a positive association with mitochondria content (16). Hancock et al., however, question the physiological impact of reduced mitochondrial content and present an excellent argument that even a 30% reduction in mitochondrial number would hardly be expected to significantly affect overall rates of muscle fatty acid oxidation during basal or normal freeliving conditions. Although more substantial mitochondrial dysfunction may still impair muscle oxidation, the authors' data stress the need for more quantitative studies of muscle lipid fluxes and their controlling factors in insulin-resistant states.
Overall, the insightful article by Hancock et al. (4) has provided important new information regarding the proposed link between mitochondrial metabolism and insulin sensitivity. Their finding of a dissociation between muscle mitochondrial function and insulin resistance complements other recent studies (5, 17, 18) and highlights the need for further research to determine the role of mitochondrial metabolism in the etiology of insulin resistance in muscle.
